1. 1321 Efficacy and safety of trabectedin (T) or dacarbazine (D) in an elderly patient subgroup (65 years) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) after prior chemotherapy. (September 2015) Authors: Von Mehren, M.; Demetri, G.D.; Schuetze, S.M.; Jones, R.L.; Milhem, M.; Elias, A.; Van Tine, B.A.; Hamm, J.; Khokhar, N.Z.; McCarthy, S.; Park, Y.C.; Knoblauch, R.E.; Parekh, T.V.; Maki, R.G.; Patel, S.R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3403 Final overall survival (OS) analysis of the randomized phase 3 study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS). (September 2015) Authors: Patel, S.; Mehren, M. Von; Reed, D.; Agulnik, M.; Kaiser, P.; Charlson, J.; Kraft, A.; Hamm, J.; Karnad, A.; Ryan, C.; Rushing, D.; Meyer, C.; Khokhar, N.Z.; McCarthy, S.; Park, Y.C.; Knoblauch, R.E.; Parekh, T.V.; Maki, R.G.; Demetri, G.D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3436 Efficacy and safety of trabectedin (T) or dacarbazine (D) for treatment of patients (pts) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) after prior chemotherapy. (September 2015) Authors: Demetri, G.; Patel, S.R.; Thomas, S.; Livingston, M.; Undevia, S.D.; Richardson, G.; Singh, A.S.; Seth, R.; Forscher, C.; Hinshaw, I.; Hussein, A.; D'Amato, G.; Chawla, S.; Khokhar, N.Z.; Park, Y.C.; Knoblauch, R.E.; Parekh, T.V.; Maki, R.G.; Mehren, M. Von Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗